A homogeneous cell-based assay to measure nuclear translocation using β-galactosidase enzyme fragment complementation

被引:16
作者
Fung, P. [1 ]
Peng, K. [1 ]
Kobel, P. [1 ]
Dotimas, H. [1 ]
Kauffman, L. [1 ]
Olson, K. [1 ]
Eglen, R. M. [1 ]
机构
[1] DiscoveRx Corp, Res & Dev, Fremont, CA 94538 USA
关键词
D O I
10.1089/adt.2006.4.263
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Positional complementation describes the use of homogeneous assays using ss-galactosidase (ss gal) enzyme fragment complementation to detect cellular protein translocation. This phenomenon occurs when the protein of interest, recombinantly expressed as a fusion protein with a modified alpha fragment of ss gal, translocates to a cellular compartment expressing an enzyme acceptor fragment of the enzyme. When these fragments interact, high-affinity complementation occurs, and a signal is generated that is then detected upon cell lysis. In the present paper the use of positional complementation is exemplified by measuring nuclear translocation of the glucocorticoid receptor in Chinese hamster ovary-K1 cells. The approach thus provides for homogeneous protocols, in an end-point microliter plate assay format, without the use of either imaging or reporter gene techniques. Consequently, these characteristics suggest that the technique is suitable for automated instrumentation protocols used in high throughput screening campaigns designed to identify activators or inhibitors of nuclear translocation.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 28 条
[1]
High content screening applied to large-scale cell biology [J].
Abraham, VC ;
Taylor, DL ;
Haskins, JR .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (01) :15-22
[2]
Comley J, 2005, DRUG DISC WORLD, V6, P31
[3]
Enzyme fragment complementation: A flexible high throughput screening assay technology [J].
Eglen, RM .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2002, 1 (01) :97-104
[4]
Eglen RM, 2003, COMB CHEM HIGH T SCR, V6, P381
[5]
Emerging trends in high-throughput screening [J].
Entzeroth, M .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (05) :522-529
[6]
Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton [J].
Galigniana, MD ;
Scruggs, JL ;
Herrington, J ;
Welsh, MJ ;
Carter-Su, C ;
Housley, PR ;
Pratt, WB .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (12) :1903-1913
[7]
Advances in high content screening for drug discovery [J].
Giuliano, KA ;
Haskins, JR ;
Taylor, DL .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (04) :565-577
[8]
A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists [J].
Golla, R ;
Seethala, R .
JOURNAL OF BIOMOLECULAR SCREENING, 2002, 7 (06) :515-525
[9]
Trafficking of nuclear receptors in living cells [J].
Hager, GL ;
Lim, CS ;
Elbi, C ;
Baumann, CT .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 74 (05) :249-254
[10]
Effects of glucocorticoids on gene transcription [J].
Hayashi, R ;
Wada, H ;
Ito, K ;
Adcock, IM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 500 (1-3) :51-62